Skip to main contentSkip to navigation
Sirius Investors

LFST Stock: LifeStance Health Group, Inc. Stock Price, Analysis & Insights

Get live lfst stock price $6.25, comprehensive LifeStance Health Group, Inc. stock analysis, charts, news, and expert forecast. Real-time lfst stock data and investment insights.

6.25
29.94%Today
LFSTLifeStance Health Group, Inc. • NASDAQ Global Select • Healthcare
Market Cap
2.43B
Volume
10.39M
52W High
8.29
52W Low
3.74
Upgrade to Pro or Premium to access long-term historical data (3M, 6M, 1Y, 2Y, 5Y, 10Y, Max)

Loading chart...

Company Overview

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.

Company Information

CEO
David Patrick Bourdon
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
7535

Contact Information

Address
4800 N. Scottsdale Road
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Care Facilities

Investment Highlights

Strong presence in the Healthcare sector with established market position

Business Model & Strategy

LifeStance Health Group, Inc. operates in the Medical - Care Facilities industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO David Patrick Bourdon, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Care Facilities model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.

Market Position & Competitive Landscape

LifeStance Health Group, Inc. competes in the Medical - Care Facilities within the broader Healthcare. With 2.4 billion in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, LifeStance Health Group, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating LifeStance Health Group, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for LifeStance Health Group, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for LifeStance Health Group, Inc.
  • Investors should consider how LifeStance Health Group, Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

2.43B

P/E Ratio

-156.25

Beta

1.15

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 2.43B market capitalization
  • Trading Volume: 10.39M shares traded today
  • Price Range: 52-week range of $3.74 - $8.29
  • Exchange: Listed on NASDAQ Global Select

Financial Metrics

P/E Ratio:-156.25
EPS:$-0.04
Beta:1.15
Avg Volume:2.10M

Market Analysis for LifeStance Health Group, Inc.

LifeStance Health Group, Inc. (LFST) operates in the Medical - Care Facilities industry within the Healthcare sector. With a current market capitalization of 2.43B, the company represents a significant player in its market. The stock is currently trading at $6.25 with a positivedaily change of 29.94%.

The company's 7535 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -156.25, beta of 1.15, and 52-week price range from $3.74 to $8.29when evaluating investment opportunities.

Why Invest in LifeStance Health Group, Inc.?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Global Select)
  • • Experienced leadership under David Patrick Bourdon
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.